KalVista Pharmaceuticals (KALV) Financial Statements

KalVista Pharmaceuticals's market cap is currently $766.79M. The company's EPS TTM is $; its P/E ratio is -3.79; KalVista Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.